Patents by Inventor Edward A. McDonald

Edward A. McDonald has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11042135
    Abstract: This disclosure describes computer-implemented techniques that enable users to control and coordinate a set of network-enabled home automation devices. Users may generate, customize, and share home automation device dashboards. These dashboards may include user interface elements, such as tiles, that users may use to determine that status of home automation devices and send commands to the home automation devices. In some examples, users may use timeline-based user interfaces to schedule actions to be performed by home automation devices.
    Type: Grant
    Filed: October 12, 2018
    Date of Patent: June 22, 2021
    Assignee: SmartHome Ventures LLC
    Inventors: Mark Edward Rolston, Kevin Michael McDonald, James Arthur Watkins, II, Steven Jay Bosch
  • Patent number: 10869773
    Abstract: A prosthetic finger includes a main body and a terminal gripper at an end of the main body for enabling fine-motor grasping skills. The terminal gripper has at least two tongs movable relative to one another. The prosthetic finger includes a gripping mode and a flexion mode. In the gripping mode, the tongs of the terminal gripper are able to move relative to one another while the main body is not able to flex, and in the flexion mode, the main body is able to flex while the at two tongs is not able to move relative to one another.
    Type: Grant
    Filed: October 10, 2018
    Date of Patent: December 22, 2020
    Assignee: College Park Industries, Inc.
    Inventors: Carlos Humberto Martinez-Luna, Michael Alfred Delph, II, Taylor Raven Duckworth, Todd Richard Farrell, Thane Robert Hunt, Craig Malone Kelly, Kevin Edward Keough, Carlton Winslow King, Benjamin Douglas Pulver, Todd William Roberts, Benjamin Edward McDonald
  • Publication number: 20200163782
    Abstract: A system and method for transmission of a signal for a powered assistive device has a sensor node with a wireless transmitter adapted for digitally transmitting a transmitted signal, the sensor node adapted for receiving and monitoring a sensor signal from a sensor attached to a user, and a master node with a controller and a wireless receiver for receiving the transmitted signal from the wireless transmitter. The master node processes the transmitted signal and communicates a control signal to the powered assistive device. The wireless transmitter transmits the transmitted signal at a first rate when the wireless transmitter adapted to transmit the transmitted signal at a first rate when the sensor signal is indicative of the rest state and to transmit the transmitted signal at a second rate when the sensor signal is indicative of the active state, the second rate being greater than the first rate.
    Type: Application
    Filed: November 27, 2019
    Publication date: May 28, 2020
    Applicant: Worcester Polytechnic Institute
    Inventors: Benjamin Edward McDonald, Todd Richard Farrell, Edward Clancy, Jianan Li, Xinming Huang
  • Publication number: 20200108964
    Abstract: An apparatus for heat shrinking packages includes a mover having an active surface configured for receiving one or more packages and for displacing the one or more packages along a predetermined operating path, a heating fluid circuit configured to circulate a heating fluid, a control unit operative on the heating fluid circuit, the control unit being configured to control circulation of the heating fluid in the heating fluid circuit, a chamber having an opening and being configured for receiving the one or more packages positioned on the active surface and for heat shrinking the one or more packages based on circulation of the heating fluid in the heating fluid circuit, and means for forming a liquid curtain arranged at the opening and configured to define a liquid curtain along the opening, the liquid curtain separating an inner volume of the chamber from an ambient atmosphere external to the chamber.
    Type: Application
    Filed: December 21, 2017
    Publication date: April 9, 2020
    Inventors: Peter Thürig, Stefan Landolt, Gregory Edward McDonald
  • Publication number: 20190358241
    Abstract: Isoxazoles of formula (A) or (B) are inhibitors of HSP90 activity, and useful for treatment of, for example cancers: wherein R1, is a group of formula (IA): —Ar1-(Alk1)p-(Z)r-(Alk2)s-Q, wherein in any compatible combination Ar1 is an optionally substituted aryl or heteroaryl radical, Alk1 and Alk2 are optionally substituted divalent C1-C6 alkylene or C2-C6 alkenylene radicals, p, r and s are independently 0 or 1, Z is -0-, —S—, —(C?O)—, —(C?S)—, —SO.sub.
    Type: Application
    Filed: July 31, 2019
    Publication date: November 28, 2019
    Inventors: Martin James Drysdale, Brian William Dymock, Harry Finch, Paul Webb, Edward McDonald, Karen Elizabeth James, Kwai Ming Cheung, Thomas Peter Matthews
  • Patent number: 10413550
    Abstract: Isoxazoles of formula (A) or (B) are inhibitors of HSP90 activity, and useful for treatment of, for example cancers: wherein R1, is a group of formula (IA): —Ar1-(Alk1)p-(Z)r-(Alk2)s-Q, wherein in any compatible combination Ar1 is an optionally substituted aryl or heteroaryl radical, Alk1 and Alk2 are optionally substituted divalent C1-C6 alkylene or C2-C6 alkenylene radicals, p, r and s are independently 0 or 1, Z is —O—, —S—, —(C?O)—, —(C?S)—, —SO.sub.
    Type: Grant
    Filed: June 23, 2017
    Date of Patent: September 17, 2019
    Assignees: The Institute of Cancer Research, Cancer Research Technology Limited, Vernalis (R&D) Limited
    Inventors: Martin James Drysdale, Brian William Dymock, Harry Finch, Paul Webb, Edward McDonald, Karen Elizabeth James, Kwai Ming Cheung, Thomas Peter Matthews
  • Publication number: 20190105184
    Abstract: A prosthetic finger includes a main body and a terminal gripper at an end of the main body for enabling fine-motor grasping skills. The terminal gripper has at least two tongs movable relative to one another. The prosthetic finger includes a gripping mode and a flexion mode. In the gripping mode, the tongs of the terminal gripper are able to move relative to one another while the main body is not able to flex, and in the flexion mode, the main body is able to flex while the at two tongs is not able to move relative to one another.
    Type: Application
    Filed: October 10, 2018
    Publication date: April 11, 2019
    Inventors: Carlos Humberto Martinez-Luna, Michael Alfred Delph, II, Taylor Raven Duckworth, Todd Richard Farrell, Thane Robert Hunt, Craig Malone Kelly, Kevin Edward Keough, Carlton Winslow King, Benjamin Douglas Pulver, Todd William Roberts, Benjamin Edward McDonald
  • Publication number: 20180295869
    Abstract: There is provided a food composition comprising at least one edible oil in a gel matrix wherein the composition is a flexible cohesive solid at a temperature in a range of from 3° to 6° C. The composition can contain cocoa solids and/or other edible ingredients such as food pastes, fruit preparations, jams and the like. In at least some embodiments the composition can be provided in sheet form, typically with a thickness in a range of from 2 mm to 6 mm. The composition can be used as a snack by itself or be provided on other food items as an edible layering and further, can be provided in packaged slice form. In a further embodiment there is provided a package of sheets or slice of the composition. There is also described a method for providing the composition.
    Type: Application
    Filed: October 5, 2016
    Publication date: October 18, 2018
    Inventors: Salvatore Villa, EDWARD MCDONALD
  • Patent number: 10065871
    Abstract: In a process for the treatment of wastewater containing carbonaceous and nitrogenous contaminants, wastewater is mixed with aerobic microorganisms capable of converting carbonaceous biological oxygen demand (CBOD) into carbon dioxide, water, and biological cell mass. Oxygen is supplied to the reaction mixture for supporting reduction of the CBOD by the aerobic microorganisms in the reaction mixture. To substantially prevent nitrification of the nitrogenous contaminants in the reaction mixture and avoid the cost of downstream denitrification, the hydraulic residence time of the nitrogenous contaminants in the reaction mixture is controlled by removing partially treated water with dissolved ammonia from the reaction mixture, while retaining the biological cell mass in the reaction mixture. This separates the nitrogen load from the carbon load and enables independent treatment of these contaminants.
    Type: Grant
    Filed: August 19, 2016
    Date of Patent: September 4, 2018
    Assignee: BluMetric Environmental Inc.
    Inventors: Danny Lee Scroggins, Ross Edward McDonald, Erik Hefler Donaldson
  • Patent number: 9996058
    Abstract: The subject matter disclosed herein relates to end devices (e.g., meters, sensors, pumps, etc.) of an industrial monitoring system or an industrial control system. A system includes an end device having processing circuitry configured to execute instructions stored in at least one memory device to enable the end device to collect and store a plurality of measurements of operational parameters of a monitored system in the at least one memory device according to a dynamic mapping that is updatable.
    Type: Grant
    Filed: December 19, 2013
    Date of Patent: June 12, 2018
    Inventors: Mikhail Brusilovsky, Benjamin Edward McDonald
  • Patent number: 9833548
    Abstract: The present invention is directed to an implantable drug depot useful for reducing, preventing or treating post-operative pain in a patient in need of such treatment, the implantable drug depot comprising a therapeutically effective amount of clonidine or pharmaceutically acceptable salt thereof and a polymer; wherein the depot is implantable at a site beneath the skin to reduce, prevent or treat post-operative pain, and the depot is capable of releasing (i) about 5% to about 45% of the clonidine or pharmaceutically acceptable salt thereof relative to a total amount of the clonidine or pharmaceutically acceptable salt thereof loaded in the drug depot over a first period of up to 48 hours and (ii) about 55% to about 95% of the clonidine or pharmaceutically acceptable salt thereof relative to a total amount of the clonidine or pharmaceutically acceptable salt thereof loaded in the drug depot over a subsequent period of at least 3 days.
    Type: Grant
    Filed: December 14, 2015
    Date of Patent: December 5, 2017
    Assignee: Warsaw Orthopedic, Inc.
    Inventors: William F. McKay, Amira Wohabrebbi, Vanja Margareta King, Phillip Edward McDonald, Christopher M. Hobot, Troy Carter
  • Publication number: 20170326152
    Abstract: Isoxazoles of formula (A) or (B) are inhibitors of HSP90 activity, and useful for treatment of, for example cancers: wherein R1, is a group of formula (IA): —Ar1-(Alk1)p-(Z)r-(Alk2)s-Q, wherein in any compatible combination Ar1 is an optionally substituted aryl or heteroaryl radical, Alk1 and Alk2 are optionally substituted divalent C1-C6 alkylene or C2-C6 alkenylene radicals, p, r and s are independently 0 or 1, Z is -0-, —S—, —(C?O)—, —(C?S)—, —SO.sub.
    Type: Application
    Filed: June 23, 2017
    Publication date: November 16, 2017
    Inventors: Martin James Drysdale, Brian William Dymock, Harry Finch, Paul Webb, Edward McDonald, Karen Elizabeth James, Kwai Ming Cheung, Thomas Peter Matthews
  • Patent number: 9775882
    Abstract: Medical devices and methods including polymers having biologically active agents therein are disclosed. The medical devices can be useful as implantable devices such as orthopedic implants.
    Type: Grant
    Filed: September 19, 2008
    Date of Patent: October 3, 2017
    Assignee: Medtronic, Inc.
    Inventors: Phillip Edward McDonald, Christopher M. Hobot
  • Patent number: 9763917
    Abstract: Effective treatments of pain for extended periods of time are provided. Through the administration of an effective amount of clonidine at or near a target site, one can relieve pain caused by diverse sources, including but not limited to spinal disc herniation (i.e. sciatica), spondilothesis, stenosis, discogenic back pain and joint pain, as well as pain that is incidental to surgery. When appropriate formulations are provided within biodegradable polymers, this relief can be continued for at least three days. In some embodiments, the relief can be for at least twenty-five days, at least fifty days, at least one hundred days, at least one hundred and thirty-five days or at least one hundred and eighty days.
    Type: Grant
    Filed: January 29, 2015
    Date of Patent: September 19, 2017
    Assignee: Warsaw Orthopedic, Inc.
    Inventors: John Myers Zanella, Christopher M. Hobot, Danielle L. Biggs, Katara Shaw, Phillip Edward McDonald, Vanja Margareta King, William F. McKay, Kathy L. Remsen
  • Patent number: 9718793
    Abstract: Isoxazoles of formula (A) or (B) are inhibitors of HSP90 activity, and useful for treatment of, for example cancers: wherein R1, is a group of formula (IA): —Ar1-(Alk1)p-(Z)r-(Alk2)s-Q, wherein in any compatible combination Ar1 is an optionally substituted aryl or heteroaryl radical, Alk1 and Alk2 are optionally substituted divalent C1-C6 alkylene or C2-C6 alkenylene radicals, p, r and s are independently 0 or 1, Z is —O—, —S—, —(C?O)—, —(C?S)—, —SO.sub.
    Type: Grant
    Filed: June 27, 2013
    Date of Patent: August 1, 2017
    Assignees: Vernalis (R&D) Ltd., Cancer Research Technology Limited, The Institute of Cancer Research
    Inventors: Martin James Drysdale, Brian William Dymock, Harry Finch, Paul Webb, Edward McDonald, Karen Elizabeth James, Kwai Ming Cheung, Thomas Peter Matthews
  • Patent number: 9585872
    Abstract: Effective treatments of pain for extended periods of time are provided. Through the administration of an effective amount of clonidine at or near a target site, one can relieve pain caused by diverse sources, including but not limited to spinal disc herniation (i.e. sciatica), spondilothesis, stenosis, discogenic back pain and joint pain, as well as pain that is incidental to surgery. When appropriate formulations are provided within biodegradable polymers, this relief can be continued for at least three days. In some embodiments, the relief can be for at least twenty-five days, at least fifty days, at least one hundred days, at least one hundred and thirty-five days or at least one hundred and eighty days.
    Type: Grant
    Filed: January 29, 2015
    Date of Patent: March 7, 2017
    Assignee: Warsaw Orthopedic, Inc.
    Inventors: John Myers Zanella, Christopher M. Hobot, Danielle L. Biggs, Katara Shaw, Phillip Edward McDonald, Vanja Margareta King, William F. McKay, Kathy L. Remsen
  • Patent number: 9549920
    Abstract: The present invention is directed to an implantable drug depot useful for reducing, preventing or treating post-operative pain in a patient in need of such treatment, the implantable drug depot comprising a polymer and a therapeutically effective amount of a local anesthetic or pharmaceutically acceptable salt thereof, wherein the drug depot is implantable at a site beneath the skin to reduce, prevent or treat post-operative pain, and the drug depot is capable of releasing (i) a bolus dose of the local anesthetic or pharmaceutically acceptable salt thereof at a site beneath the skin and (ii) a sustained release dose of an effective amount of the local anesthetic or pharmaceutically acceptable salt thereof over a period of at least 4 days.
    Type: Grant
    Filed: September 29, 2014
    Date of Patent: January 24, 2017
    Assignee: Warsaw Orthopedic, Inc.
    Inventors: Amira Wohabrebbi, William F. McKay, Vanja Margareta King, Danielle L. Biggs, Katara Shaw, Christopher Hobot, Phillip Edward McDonald
  • Publication number: 20160095963
    Abstract: The present invention is directed to an implantable drug depot useful for reducing, preventing or treating post-operative pain in a patient in need of such treatment, the implantable drug depot comprising a therapeutically effective amount of clonidine or pharmaceutically acceptable salt thereof and a polymer; wherein the depot is implantable at a site beneath the skin to reduce, prevent or treat post-operative pain, and the depot is capable of releasing (i) about 5% to about 45% of the clonidine or pharmaceutically acceptable salt thereof relative to a total amount of the clonidine or pharmaceutically acceptable salt thereof loaded in the drug depot over a first period of up to 48 hours and (ii) about 55% to about 95% of the clonidine or pharmaceutically acceptable salt thereof relative to a total amount of the clonidine or pharmaceutically acceptable salt thereof loaded in the drug depot over a subsequent period of at least 3 days.
    Type: Application
    Filed: December 14, 2015
    Publication date: April 7, 2016
    Inventors: William F. McKay, Amira Wohabrebbi, Vanja Margareta King, Phillip Edward McDonald, Christopher M. Hobot, Troy Carter
  • Patent number: 9259827
    Abstract: A tool for holding and applying torque to a nut including a keyway. The tool includes a longitudinal body having a longitudinal axis and a body channel. A longitudinal key is disposed in the body channel with one end of the key configured to engage the keyway of the nut. A first key portion contacts the body channel while a second key portion extends over the body channel forming a gap between the key and the body channel prior to insertion of the key into the keyway of the nut. The second key portion is configured to be resiliently deflected radially inward toward the longitudinal axis of the longitudinal body when the second key portion engages the keyway of the nut.
    Type: Grant
    Filed: October 11, 2013
    Date of Patent: February 16, 2016
    Assignee: General Electric Company
    Inventors: Mykhaylo Barsukov, Benjamin Edward McDonald
  • Patent number: 9211285
    Abstract: The present invention is directed to an implantable drug depot useful for reducing, preventing or treating post-operative pain in a patient in need of such treatment, the implantable drug depot comprising a therapeutically effective amount of clonidine or pharmaceutically acceptable salt thereof and a polymer; wherein the depot is implantable at a site beneath the skin to reduce, prevent or treat post-operative pain, and the depot is capable of releasing (i) about 5% to about 45% of the clonidine or pharmaceutically acceptable salt thereof relative to a total amount of the clonidine or pharmaceutically acceptable salt thereof loaded in the drug depot over a first period of up to 48 hours and (ii) about 55% to about 95% of the clonidine or pharmaceutically acceptable salt thereof relative to a total amount of the clonidine or pharmaceutically acceptable salt thereof loaded in the drug depot over a subsequent period of at least 3 days.
    Type: Grant
    Filed: December 5, 2013
    Date of Patent: December 15, 2015
    Assignee: Warsaw Orthopedic, Inc.
    Inventors: William F. McKay, Amira Wohabrebbi, Vanja Margareta King, Phillip Edward McDonald, Christopher M. Hobot, Troy Carter